Skip to main content

Not investment advice.Read full disclaimer

ITRM: Iterum Therapeutics plc Company Profile & Overview | finqOS

Healthcare · Biotechnology

52W Range

0thpctl

Volume

3.02×avg

Market Cap

1.60MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Continue with finqOS

Get the full profile on Iterum Therapeutics plc

Executive team, business description, key stats, and everything you need to understand the company.

Start Free Trial→Sign In

14-day free trial · No credit card required

Iterum Therapeutics plc

ITRMNASDAQ Capital Market·USD·Closed

Iterum Therapeutics plc

ITRMNASDAQ·USD·Closed

$0.03

−10.98%

$0.03

−$0.00 (10.98%)

52W Range

0thpctl

Volume

3.02×avg

Mkt Cap

1.60MUSD

P/E

-0.1TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings